August 31, 2010 — Chiral Technologies Worldwide will showcase their custom separation service capabilities at the Pharma ChemOutsourcing Conference & Exhibition, Booth 42.
Chief Operating Officer Joseph Barendt, Ph.D., Chiral Technologies Inc., is participating in the panel discussion on “Chiral Synthesis: Early Project Application to Minimize Process Modification” at 4:30 p.m., Wednesday, Sept. 15. Dr. Barendt has more than 20 years of experience in the field of
Chiral Technologies Worldwide, supporting pharmaceutical and biopharmaceutical companies in their quest to develop single-enantiomer drugs, provides custom separation services for rapid isolation of pure enantiomers from racemic mixtures at scales ranging from milligrams to multi-kilograms.
Visit Booth 42 for interviews with Chiral Technologies Worldwide experts, or visit http://www.chiraltech.com/sep_overview.asp.